[YMAB] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -141.81%
YoY-
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 23,363 31,447 9,598 20,750 0 0 0 -
PBT -793 1,157 -36,893 -19,933 -23,136 -14,060 -9,254 -33.58%
Tax 195 1,558 1,135 2,086 -79 0 -9,275 -
NP -988 -401 -36,893 -19,933 -23,136 -14,060 -9,254 -31.11%
Tax Rate - -134.66% - - - - - -
Total Cost 24,351 31,848 46,491 40,683 23,136 14,060 9,254 17.48%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -4.23 -1.28 -384.38 -96.06 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.02 -0.01 -0.85 -0.48 -0.61 -0.41 -0.28 -35.57%
EPS Diluted -0.02 -0.01 -0.85 -0.45 -0.58 -0.41 -0.28 -35.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.